Gartnavel General Hospital

Glasgow G12 0YN

1 studies enrolling now · 13 studies all time

What they study most

Acute Myeloid Leukemia, Asthma, Atypical Hemolytic Uremic Syndrome, B-cell Chronic Lymphocytic Leukemia, Chronic Hepatitis, Haematological Malignancy, Hepatitis B, Higher-risk Myelodysplastic Syndrome, Multiple Myeloma, Non Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Prostate Cancer

Studies at this site

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies — Recruiting now
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene — Running, not enrolling
Registry of Asthma Patients Initiating DUPIXENT® — Completed
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease — Running, not enrolling
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene — Completed
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy — Completed
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
aHUS Observational Long Term Follow-Up — Stopped early
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus — Stopped early
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus — Stopped early
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed